ÜRÜN, Y. Et Al. 2015. Prognostic factors for survival in patients with metastatic melanoma treated with ipilimumab: Turkish Oncology Group (TOG) Study. European Cancer Congress , (Vienna, Austria).

ÜRÜN, Y., Abali, H., Turna, H., Esin, E., Sedef, A. M., Alkan, A., ... Oksuzoglu, B.(2015). Prognostic factors for survival in patients with metastatic melanoma treated with ipilimumab: Turkish Oncology Group (TOG) Study . European Cancer Congress, Vienna, Austria

ÜRÜN, YÜKSEL Et Al. "Prognostic factors for survival in patients with metastatic melanoma treated with ipilimumab: Turkish Oncology Group (TOG) Study," European Cancer Congress, Vienna, Austria, 2015

ÜRÜN, YÜKSEL Et Al. "Prognostic factors for survival in patients with metastatic melanoma treated with ipilimumab: Turkish Oncology Group (TOG) Study." European Cancer Congress , Vienna, Austria, 2015

ÜRÜN, Y. Et Al. (2015) . "Prognostic factors for survival in patients with metastatic melanoma treated with ipilimumab: Turkish Oncology Group (TOG) Study." European Cancer Congress , Vienna, Austria.

@conferencepaper{conferencepaper, author={YÜKSEL ÜRÜN Et Al. }, title={Prognostic factors for survival in patients with metastatic melanoma treated with ipilimumab: Turkish Oncology Group (TOG) Study}, congress name={European Cancer Congress}, city={Vienna}, country={Austria}, year={2015}}